Drug profile · INN
fingolimod lauryl sulfate
TASCENSO ODT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fingolimod lauryl sulfate (TASCENSO ODT) is an FDA-listed pharmaceutical active ingredient. Associated with BICYCLE THERAPEUTICS. Route of administration: oral. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is fingolimod lauryl sulfate?
fingolimod lauryl sulfate (TASCENSO ODT) is an FDA-listed pharmaceutical active ingredient. Associated with BICYCLE THERAPEUTICS. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fingolimod lauryl sulfate?
TASCENSO ODT is a marketed brand name for fingolimod lauryl sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fingolimod lauryl sulfate?
fingolimod lauryl sulfate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.